Sign up
Pharma Capital

WideCells to save £400,000 a year from streamlining WideAcademy division

WideCells is now “fully focused” on growing sales in its two core divisions: Cell Plan and WideCells
stem cell
WideAcademy is an education and training division designed to promote benefits of stem cell storage

WideCells Group PLC (LON:WDC) has streamlined its WideAcademy business, saving the stem cells services company around £400,000 a year.

As part of the restructuring, WideAcademy’s senior vice president Alan Greenberg, who is also chief business development officer and a director of the board, has resigned from his positions.

READ: WideCells inks “seminal” stem cell insurance deal

The London office of WideAcademy has also been closed with all operations shifting to the head office in Manchester.

“The streamlined board and Wideacademy are now fully focused on increasing sales at our two core divisions - CellPlan, the world's first stem cell healthcare insurance plan; and WideCells, focused on stem cell storage and, research, in order to generate value for our shareholders," said chief executive João Andrade.

Shares surged 53% to 0.46p in mid-afternoon trading on Tuesday.

-- Updates for share price --

View full WDC profile View Profile

What is social first publishing?

View All

Related Articles

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.